What the results of Wegovy’s longest clinical trial yet show about ...
WEBMay 13, 2024 — New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
Ozempic, Wegovy linked to severe medical conditions ... - NBC News
WEBPeople who take popular drugs for weight loss, such as Ozempic or Wegovy, may be at an increased risk of severe stomach problems, research published Thursday in the Journal of the American...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
WEBToday, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults...
FDA Approves New Drug Treatment for Chronic Weight …
WEBFDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ for ...
WEBAug 25, 2023 — A study found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a 100-point scale that’s used to assess symptoms of a...
Why weight-loss drug Wegovy shows promise for heart disease - NBC News
WEBNov 11, 2023 — A new clinical trial found that weight-loss drug Wegovy shows promise for lowering the risk of heart attack and stroke among people with heart disease and obesity.
Wegovy approved to lessen heart attack, stroke risk in overweight ...
WEBMar 8, 2024 — The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in...
FDA approves Wegovy to reduce heart attack and stroke risk - NBC News
WEBMar 8, 2024 — The blockbuster weight loss drug Wegovy is now approved to reduce heart disease risk, drugmaker Novo Nordisk said Friday. The Food and Drug Administration has updated the drug's label, saying...
Wegovy Cuts Risk of Heart Problems, Novo Nordisk Trial Says
WEBAug 8, 2023 — A new obesity drug, Wegovy, slashed the risk of serious heart problems by 20 percent in a large trial, the drug’s maker said on Tuesday, a finding that could challenge the perception of weight...
Novo Nordisk Wegovy approved for cutting heart disease risks
WEBMar 8, 2024 — That decision could widen insurance coverage for the drug and similar treatments for obesity, which has been a major barrier to access for patients.